TrialUrology2024

A Phase II Prospective Blinded Trial of Magnetic Resonance Imaging and In-Bore Biopsy in Active Surveillance for Prostate Cancer.

Bjoern J Langbein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.